Delpharm Development Leiden B.V.

About

Delpharm Development Leiden B.V. is a leading Contract Development and Manufacturing Organization (CDMO) with 18 production sites across France, Italy, Canada, Poland, and the Netherlands, supporting a global portfolio of over 1 billion euros in annual turnover and employing more than 6,000 professionals. The company specializes in the full spectrum of dosage forms—from tablets and capsules to complex sterile products—delivering end‑to‑end solutions for pharmaceutical, biotech, and medical‑device clients. With three decades of experience, Delpharm distinguishes itself through a culture of transparency, customer‑centric listening, and a multidisciplinary workforce that drives operational efficiency and innovation. Its proven track record of successful projects for diverse, demanding customers positions it as a trusted partner for companies seeking reliable, high‑quality manufacturing and development services.